Abercrombie and his colleagues have accumulated evidence that changes in the heterotypic contact-inhibition response are largely responsible for the invasiveness of cells, at least in culture. We have identified a 37 000Mr protein on the surface of mouse fibrosarcoma cells that is involved in their in vitro invasion. Blocking this protein with specific antibodies inhibits the invasion of chicken heart fibroblasts bv the tumour cells and normal heterotypic contact inhibition is restored. These results are presented in the general framework of metastatic mechanisms and we review a selection of more recent studies aimed at describing the metastatic phenotype in molecular terms.
INTRODUCTION
Primary solid tumours are benign and it is the appearance of the metastatic phenotype that eventually kills the host. An understanding of the mechanisms leading to uncontrolled cell proliferation will presumably arise from the study of oncogenes. However, the biochemical changes critical for the development of metastatic potential are poorly understood. Whether oncogene activation also directs such changes is at present unclear (see below).
Attempts to recognize mechanisms required for metastasis are generally based on analysis of the sequence of events involved (Liotta et al. 1986 ). The metastatic cascade includes:
(1) Release from the primary tumour.
(2) Invasion of the epithelial basement membrane to reach the interstitial stroma.
(3) Invasion of the basement membrane and endothelial layer of the blood vessel wall (intravasation).
(4) Dissemination via the blood or lymphatics.
(5) Arrest in capillaries of another organ by adherence to endothelial cell luminal surfaces and/or exposed basement membranes.
(6) Penetration of the vascular endothelium and/or its underlying basal lamina (extravasation).
(7) Proliferation in the parenchyma of the organ. The term 'invasion' has been used in two contexts. First, to describe cell infiltration of the extracellular matrix. The basal membrane, for example, represents a type of matrix that is normally impermeable to large proteins, but becomes permeable to cell movement during tissue healing, remodelling, inflammation and neoplasia (Liotta et al. 1986 ). The in vitro systems used to study this type of invasion do not include cells additional to those of the tumour under examination. The second type of invasion, so-called cellular invasion, relates to the contact interactions between moving cells (Heaysman, 1978; Abercrombie, 1979; Paddock & Dunn, 1986) . The behaviour of two cell types during and following collision in vitro can be related to their metastatic potential in vivo (see below) . This paper summarizes a selection of the more recent studies on the metastatic cascade. It is not our aim to review the field, but a number of reviews covering earlier work are cited. Our own interests concern the cell contact-related invasive behaviour. However, we present our results in the general framework of metastatic mechanisms.
Metastasis also implies the cells are able to evade the host defences. The mechanisms involved are unknown, although both decreased and increased ex pression of the major histocompatibility complex antigens have been invoked (Hart, 1985) . The greatly reduced expression of the major histocompatibility complex found in many primary tumours suggests therapeutic approaches. Immunization with parental tumour cells in which these antigens have been induced (e.g. by transfection or interferon treatment) can afford protection against the untreated tumour cells (Tanaka et al. 1986 ). These immunological aspects are not covered here.
EXPRESSION OF THE METASTATIC PHENOTYPE

Role of oncogenes
Do oncogenes influence not only cell proliferation but also the development of the malignant phenotype? Results to date are preliminary and contradictory.
Greig et al. (1985) transfected N IH 3T3 cells with the c-Ha-ras 1 gene and found that, in the mouse, both tumorigenicity was accelerated and metastatic potential was enhanced. However, under specific conditions (e.g. inoculation in the foot pad), non-transfected N IH 3T3 cells were also metastatic. The transformed cells formed lung metastases irrespective of the site of implantation. The interpretation is that the normal cell population contains a subpopulation of cells expressing malignant properties, transfection with c-Ha-ras 1 accelerating the formation, of metastases.
Growth of transformed cells was faster in vivo, although their proliferative capacity was the same as non-transformed cells in vitro. Moreover, the culture history of the NIH 3T3 cells was found to influence their tumorigenicity.
These results underline the difficulties associated with studying immortalized cell lines and of correlating in vivo and in vitro findings. Bradley et al. (1986) found that NIH 3T3 cells transformed with a wide variety of either normal or activated mammalian ras genes, when injected into the tail vein of nude mice, formed approximately equal numbers of lung metastases. Non transfected cells failed to metastasize. The authors conclude that mutation or overexpression of ras switches on the phenotype required for metastases in N IH 3T3 cells. Moreover, they cite unpublished experiments in which first-passage rat embryo cells could be converted to the metastatic phenotype within 3'5 generations of a myc and ras transfection.
Nevertheless, it would be premature to contend that rapid transformation of cells to a metastatic phenotype is simply dependent on the appropriate activation of oncogenes. Olsson & Forchhammer (1984) induced the expression of the metastatic phenotype in a stable, non-metastatic mouse tumour following demethylation of the DNA with 5 -azacytidine. The presence of proteins specific for the metastatic cells indicates that gene activation may have occurred. The results imply that the genetic bases for tumorigenicity and metastatic activity do at least differ partly from one another.
Identification of genes bestowing the metastic phenotype
Approaches that were successful in identifying oncogenes are now being applied to the search for genes conferring metastatic potential on tumorigenic cells. Bernstein & Weinberg (1985) transfected EJ-H a-ras oncogene-transformed N IH 3T3 mouse fibroblasts with genomic DNA isolated from nine metastatic human cell lines. Cells transformed with ras and inoculated intramuscularly, subcutaneously, intraperitoneally or in the foot pad did not have a significantly high rate of metastases formation in immunocompetent mice. Tail vein injection resulted in a 50% rate of metastasis.
When D NA from a human cervical carcinoma was transfected into the rastransformed cells, one of the resulting colonies yielded lung metastases after subcutaneous injection. Second-round transfection of DNA isolated from these metastases increased the frequency of metastases formation. A human DNA fragment that remained associated with the metastatic phenotype through the two cycles of D NA passage has not been identified. However, the results indicate that the expression of a single gene may suffice, suggesting that only a small number of steps are required for tumorigenic cells to become metastatic. Alternatively, the trans fected gene(s) may confer protection against the immune system. In fact, there was uniform metastatic spread of the ras-transformed NIH 3T3 cells in immunoincompetent (irradiated) nude mice but not in immunocompetent, histocompatible animals.
Recently, Kerbel et al. (1987) found that the process of calcium phosphate mediated D N A transfection itself can lead to heritable changes in the malignant behaviour of transfected tumour cells. These changes are observed at high frequency and may be a function of the extent of genetic instability of the cell line transfected. The results raise doubts about the interpretation of transfection experiments in the study of tumour progression and metastasis since they show that products of a transferred gene may not be responsible for the observed phenotype of transfectants.
Antioncogenes
Malignancy can be suppressed when malignant and non-malignant cells are fused (Stanbridge, 1976; Harris, 1986) , suggesting that tumours may arise as a conse quence of recessive mutations in somatic cells. Such recessive cancer genes or antioncogenes (so named because of the antioncogenic effect of the presence of one allele) have also been identified through the study of heriditary cancer (Knudson, 1986) . (Harris (1986) argued that no cellular genes acting to produce tumours in a genetically dominant fashion have been found.) Antioncogenes differ from onco genes in being inactive in malignant cells and cancer occurs when no normal copy is present. The normal alleles are probably important tissue-regulation genes, perhaps regulating the expression of one or more oncogenes and/or growth factors. Their role in metastasis is unknown.
ADHESIVE PROPERTIES OF METASTATIC CELLS
Adhesion to the vascular endothelium
The first barrier to cells that are disseminated throughout the vascular system is the endothelial lining of capillaries (Weiss, 1976; Fidler, 1978) . Tumour cells must adhere to the endothelium before passing through it. Auerbach & Joseph (1984) postulated that capillary endothelial cells differ in their surface antigens, the differences reflecting their developmental history. The distinct organ-associated antigens on their surfaces would determine the tumour types that recognize and adhere to them. This would explain the preferential metastasis of tumours to various organs in the body (Weiss, 1976; Fidler, 1978; Fidler & Hart, 1982) . To examine the role of differential tumour cell adhesion in preferential metastasis, Alby & Auerbach (1984) used endothelial cells from mouse brain capillaries or ovaries in an in vitro assay system for adhesion. They found that ovary-derived teratoma cells and a testicular teratoma with ovary seeding properties adhered preferentially to ovary endothelial cells. On the other hand, glioma cells, an endothelioma and a bladder tumour line adhered preferentially to the brain endothelial cells. Hence, cell surface differences that can be distinguished by tumour cells are present on endothelial cells derived from different sources.
At present, too few endothelial cell types are available for study to validate the model. However, lymphocyte homing studies demonstrate clearly the importance of endothelial cell specificity in regulating the extravasation of circulating cells (Chin et al. 1983) . Lymphocyte adherence to and penetration through specialized endothelial cells depend on the presence of specific adherence molecules on the endothelial cells. Moreover, there is organ specificity in this lymphocyte-endothelial cell interactive system (Gallatin et al. 1983) .
Adhesion to the basement membrane
Adhesion of tumour cells to the subendothelial matrix might also be expected to be a prerequisite for extravasation (Kramer & Nicolson, 1979) . Many metastatic cells bind preferentially to basement membrane (type IV) collagen using laminin as an attachment protein (Terranova et al. 1986 ).
Vollmers & Birchmeier (1983) have selected monoclonal antibodies that block the adhesion of mouse B16 melanoma cells to tissue culture dishes. The antibodies recognized antigens on the B16 cells but not on normal mouse cells. The monoclonal antibodies, when either preabsorbed by the melanoma cells or injected intraperitoneally before tumour cells, were found to abolish lung colonization by tail-veininjected B16 lines.
Such results raise hopes that identification of molecules involved in endothelial or matrix adhesion will open the way to clinical treatment with antibodies. Unfortu nately, tumour cells appear to have a variety of molecules that can assist adhesion, and inhibition of one such molecule with antibodies may simply select for cells with alternative adhesion mechanisms. Clearly, the heterogeneity and plasticity of metastasizing cells is an enigma facing any antigen-directed treatment.
Adhesion in the primary tumour
Certain cell adhesion molecules (CAMS) have been identified. N-CAM, the adhesion molecule from nerve tissue, is implicated in nerve fasciculation, nervemuscle binding, the development of retinal layers in organ culture, and early embryonic events (Edelman, 1985) . Transformation of a rat cerebellar cell line with Rous sarcoma virus resulted in decreased N-CAM expression coupled with a decrease in cell-cell adhesion (Greenberg et al. 1984) . The loss of a specific adhesion system would be expected to facilitate the detachment of tumour cells from the primary tumour and surrounding tissue. Unfortunately, the significance of the results is uncertain, since a chemically transformed cerebellar cell line had high levels of N-CAM.
Role of carbohydrate moieties
Cell surface carbohydrates appear to be involved in cell adhesiveness and recognition of target organs. The attachment and spreading of cells in vitro is modified by treatments with neuraminidase (Dennis et al. 1982) , glycosidases and lectins (Grimstad et al. 1984) . Cell surface lectins that aggregate liver-metastasizing tumour cells have been found on normal hepatocytes (Springer et al. 1983) .
Highly branched and sialylated N-linked oligosaccharides are commonly found in malignant and transformed cells and result in altered lectin-binding characteristics (Nicolson, 1982) . A direct correlation between sialylation of galactose and Nacetylgalactosamine residues and metastatic capacity has been reported (Yogeeswaran & Salk, 1981; Altvogt et al. 1983) . Swainsonine, a drug that inhibits Golgi amannosidase II and causes the formation of complex high mannose, hybrid-tvpe oligosaccharides, reduced by 80% the ability of tail-vein-injected B16 murine melanoma cells to colonize lungs (Humphries et al. 1986) . The treated cells were cleared from the lungs at a greater rate than the control cells, suggesting that tumour retention (adhesion) by the target organ was altered. These results suggest that the specific structure of the carbohydrate (orientation and/or structure) is essential for successful colonization of target organs.
TUMOUR CELL INVASION OF BASEMENT MEMBRANES
Since basement membranes line most blood vessels, thereby creating a physical barrier to the passage of cells, metastatic cells must be able to degrade as well as bind to these membranes (Jones & De Clerck, 1982) . The constitution of basement membranes is at least partly known and the levels of relevant digestive enzymes produced by tumour cells have been intensively studied. Furthermore, a variety of in vitro systems using reconstituted basement membrane-like matrices or isolated basement membranes have been employed to study directly this aspect of the invasive capacity of tumour cells.
The matrix-invasiveness or the metastatic potential of many tumours has been correlated with an increased production of proteolytic enzymes (Mullins & Rohr licht, 1983) . These include plasminogen activators (Dano et al. 1985) , lysosomal hydrolases (Sloane & Honn, 1984) and collagenases (Liotta et al. 1982) . Specific inhibitors of proteinases block tumour invasion in vitro and in vivo (Rossman & Troll, 1980) . Mignatti et al. (1986) found that invasion of the human amniotic membrane by mouse B 16/B L6 melanoma cells (selected for metastatic potential) was prevented by inhibitors of collagenase and plasmin as well as anti-urokinase antibodies. Production of serine proteinases appeared to trigger an amplification mechanism, which resulted in the sequential generation of plasmin and collagenase. The crucial step appeared to be the activation of procollagenase.
Heparanases also assist tumour cells to invade the extracellular matrix (Nakajima et al. Nicolson et al. 1985) . Certain sulphated polysaccharides inhibit the binding of lymphocytes to high endothelial venules and the passaging of lymphocytes through lymphoid organs (Brenan & Parish, 1986) . Rat lung metastasis resulting from intravenous injection of mammary adenocarcinoma cells was significantly reduced by sulphated polysaccharides (e.g. heparin, fucoidan) (Coombeei al. 1987 ).
The antimetastatic effect was independent of the ability of the polysaccharides to block coagulation. C. R. Parish et al. (unpublished) have shown that the inhibitory effect of the sulphated polysaccharides on metastasis was correlated with their inhibition of tumour cell-derived heparanases.
Although there is often a positive correlation between the ability of tumour cells to invade the extracellular matrix in vitro and their metastatic behaviour in vivo, it must be stressed that this type of invasiveness represents only a limited part of metastatic formation. Terranova et al. (1986) examined the properties of tumour cells able to penetrate a model basement membrane-stromal matrix consisting of laminin and type IV collagen reconstructed onto a disk of type I collagen. Some properties of cells derived from two tumour lines, selected for their ability to migrate through the matrix, were determined. When compared with the parent cells, the selected cells had a higher level of attachment to type IV collagen (40 and 55% ), bound more laminin (3-and 5-fold) and degraded collagen at a faster rate (2-and 2-5-fold). Moreover, when returned to the assay chambers, they penetrated new barriers 4-and 6-fold better than the parental population. Four cell lines selected in this way were examined for their ability to produce lung metastases after injection in the tail vein of mice. One of the lines produced about three times as many metastases as the parental line, whereas increases with the other three lines were between 25 and 100%. Significantly, a second round of selection produced only moderate increases in metastatic activity, indicating that this type of invasiveness accounts for only a part of metastatic behaviour.
Primary human breast cancer cells could invade a denuded human amniotic basement membrane and were diploid (Smith et al. 1985) . However, malignant effusion-derived cell cultures were aneuploid.
CELLULAR INVASION BY TUMOUR CELLS
Cellular invasion or cellular infiltration involves cell locomotion and cell-cell contact and is clearly important in both embryonic development and cancer metastasis. A number of methods have been developed to study cellular invasion both in vitro and in vivo (see Mareel et al. 1979 (see Mareel et al. , 1987 Kieler, 1984) . There is, however, no quantitative measure of cellular invasion in vivo and histological descriptions must suffice. Invasion in culture can be readily described, but its relevance to invasion in vivo is uncertain. Nevertheless, there is considerable evidence that the contact interactions between moving cells in culture result in patterns that mimic aspects of certain fundamental biological processes, including malignant invasion (Abercrombie, 1979) .
Contact inhibition and cellular invasion
Abercrombie and his colleagues (Abercrombie, 1979; Abercrombie & Heaysjman, 1953 , 1954 , 1976 Abercrombie & Turner, 1978; Abercrombie et al. 1957 Abercrombie et al. , 1968 Heaysman, 1970 Heaysman, , 1978 Stephenson & Stephenson, 1978; Paddock & Dunn, 1986) have used the confronted explant assay for assessing cellular invasion. In this method, two foci of cells (explants) are placed about 1 mm apart and the behaviour of cells is observed when the outgrowths (outwanderings) have met. Cellular invasion by metastatic cells, a distinct feature of their behaviour in vivo, can be observed in this culture system. Normal cells are not invasive in the assay. The general conclusion of many experiments is that changes in the normal contact inhibition response are the most important single factor in determining invasiveness. Since there has been some confusion in the literature about contact inhibition, it would be instructive to quote Abercrombie (1979) . He wrote: "The term contact inhibition refers to the phenomenon of a cell ceasing to continue moving in the same direction after contact with another cell. It is not always operative.... Contact inhibition is observed as one or both colliding cells stopping and perhaps immediately turning aside. Stopping does not usually occur immediately after contact has been made" . Effective cell contact is crucial for contact inhibition, since even small amounts of collagen between cells results in anomalous results.
The outward radial migration of cells from an explant reflects their mutual, homotypic contact inhibition. The homotypic contact inhibition of malignant cells is generally lower than that of non-malignant cells and the outward drive of the former is not so powerful. Whether this is related to their invasiveness is not clear. Standardized normal fibroblasts have been used as the control explant. Chicken heart fibroblasts have usually been chosen, although they can be interchanged with other fibroblasts.
Following confluence between the explants of the two different cell populations, one of three patterns ensues. First, a very high degree of obstruction with no cellular infiltration occurs. Such is the case when normal fibroblasts (e.g. from mouse muscle) are confronted with the standard chicken heart fibroblasts. The radial displacement of both cell types is greatly repressed and cells then move into the cell free space at the sides of the region of junction. Time-lapse filming indicates that the high heterotypic contact inhibition between the two non-malignant explants is responsible for the high degree of mutual obstruction. Stephenson & Stephenson (1978) reported invasion of human skin fibroblasts by chicken heart fibroblasts. However, contact inhibition between the two fibroblast populations was not defective and invasion was by diffusion-like movements into free space. It was assisted by the abandonment of territory by retreating human cells.
Second, infiltration or mixing of both cell populations may occur. Such behaviour, so-called reciprocal invasion, is observed when one of the explants consists of tumour cells that are invasive in vivo. Filming has indicated, for example, that the invasion of fibroblast populations by human melanoma cells is due to defective non-reciprocal heterologous contact inhibition (Stephenson & Stephenson, 1978) . Fibroblasts were contact-inhibited by collision of their leading edges with those of the melanoma cells. However, reciprocal invasion of the melanoma cells by the fibroblasts did occur and may have been due to diffusion-like movement of the fibroblasts into free space.
Third, malignant tumour cells occupy territory held by the normal fibroblasts but not vice versa and some infiltration usually occurs (non-reciprocal invasion). The non-reciprocal invasion of chicken heart fibroblasts by a mouse fibrosarcoma (FS9) has recently been studied in detail using film analysis of single cell collisions (Paddock & Dunn, 1986) . The invasive behaviour of the FS9 cells was not simply due to suppression or failure of the contact inhibition response. Following collision with the fibroblasts, FS9 cells showed contact promotion of locomotion, a reduced lateral displacement and a tendency to turn towards the point of initial marginal contact. Hence, FS9 cells showed an active invasory response. Moreover, after colliding with FS9 cells, the chicken heart fibroblasts showed higher levels of contact inhibition and greater lateral displacement than were induced by homotvpic collisions. This response would function to increase the invasiveness of FS9 cells. In addition to a failure of heterotypic contact inhibition, cell adhesion may be involved in tumour cell invasion in vitro. Homotypic adhesion could prevent penetration by a second cell population and strong heterotypic adhesion could obstruct the invading cells. However, since adhesion is by definition reciprocal it can hardly account for non-reciprocal invasion (Abercrombie, 1979) . Abercrombie (1979) formulated the concept of non-reciprocity (Heaysman, 1970) to explain invasion, invoking the presence of separate emittors and receptors. In this model, a tumour that induces strong contraction of a fibroblast would be a strong emittor but, when not itself inhibited by the fibroblast, it would be a weak receptor. In reciprocal inhibition, both cells would have emittors and receptors for each other.
The positive correlation between infiltration and occupation of territory by tumour cells in culture and their invasivity in vivo is encouraging. However, the contact responses are only observable in culture and it is difficult to be certain of their significance for pattern formation in vivo.
Identification of a surface protein that influences cell invasion in vitro
There is considerable evidence that changes in the surface of tumour cells are involved in the acquisition of the metastatic phenotype (Nicolson, 1982) ; however, the precise nature of these changes is not known. Moreover, it is not clear whether the same surface components are consistently involved or whether metastatic potential can be achieved by a variety of different combinations.
We wished to identify cell surface changes associated with the invasive behaviour (i.e. reduced heterotypic contact inhibition) in the confronted explant system. Our simple working hypothesis was that tumour cells become invasive as a result of either the acquisition or the loss of one or more surface proteins. We decided to use antibodies to detect and block relevant antigens, as such models have been successfully employed to study cell adhesion systems (Gerisch, 1986; Edelman, 1985) .
We selected the chemically induced mouse fibrosarcoma (FS9) for our studies, a tumour showing non-reciprocal invasion in the confronted explant assay (Abercrom bie, 1979; Paddock & Dunn, 1986) . As a control we chose the non-invasive L929 mouse tumour cell line, which has the same haplotype as FS9.
We initially purified plasma membranes from the two cell types, which were then used as a source of surface antigens. Sodium dodecyl sulphate-PAGE showed some differences in the pattern of proteins associated with the plasma membrane of FS9 and L929 cells, in particular a 37 X 103M r protein (denoted gp37) was prominent in FS9 membranes and either absent or only weakly detectable in L929 cells (Steinemann et al. 1984a) . This appeared to be a glycoprotein, since following oxidation it was reduced with borohydride. Polyclonal antibodies directed against a variety of plasma membrane proteins in both cell types were obtained. The antibodies recognizing epitopes present on both cell types were removed by absorbing the antiserum directed against FS9 plasma membranes with L929 cells and vice versa. Western blotting showed that the preabsorbed FS9 antiserum mainly contained antibodies that recognized gp37. A 5 5 x l0 3Air protein was the major antigen recognized after the L929 antiserum had been preabsorbed by FS9 cells.
The effects of the FS9 and L929 specific antisera on the invasion of chicken heart fibroblasts by FS9 cells in the confronted explant assay were examined. Fab fragments were first prepared from the antisera to avoid cell agglutination and surface deformation by divalent antibodies (Gerisch, 1986) . The Fabs specific for FS9 membranes completely inhibited the invasion of the fibroblasts by FS9 cells at concentrations above 0-8 mg ml-1. Control Fabs or those specific for L929 cells had no effect.
Since the inhibitory Fabs were largely directed against gp37, it appeared that blocking this antigen was sufficient to prevent FS9 cell invasion. However, the Fabs did bind weakly to a number of other antigens specific for FS9 plasma membranes. Consequently, we produced a variety of monoclonal antibodies (mAbs) directed against FS9 plasma membrane antigens (Steinemann et al. 19846) . We selected mAbs that preferentially bound to FS9 rather than L929 cells. Western blotting identified the mAbs directed against gp37. Fabs prepared from a gp37-specific mAb (DD9, Fig. 1 ) inhibited FS9 invasion of fibroblasts at concentrations as low as 1 ^gm l-1 (Fig. 2) . Two other mAbs recognizing different surface antigens specific for FS9 cells failed to influence invasion.
Immunofluorescence studies confirmed the presence of gp37 on the surface of FS9 cells (Steinemann et al. 1984b) . The protein does not appear to be excreted by the cells, the low levels in the medium being sedimentable and presumably attached to shedded membranes or cell debris. Using specific mAbs we have shown that gp37 is not the 37K (3 7 x l0 3M r) envelope glycoprotein of Rous sarcoma virus and is not a histocompatibility antigen. It is not related to the major excretable protein (MEP) or mitogen-releasable proteins (MRP), which have similar molecular weights and are excreted by transformed cells (see Steinemann et al. 19846 ).
gp37 binds to concanavalin A. Following tunicamycin treatment of FS9 cells a 35K antigen appears in Western blots. This antigen does not bind to a concanavalin A affinity column (L. Catanzariti, Diplomarbeit, University of Zurich, 1985) . We tentatively conclude that gp37 is A^-glycosylated, but have not been able to determine whether O-sugars are present. Apparently, the mAb (DD9) does not bind to theiVsugars.
We are currently pursuing four lines of research:
(1) Time-lapse filming of FS9-chicken heart fibroblast single cell collisions. Pre liminary experiments (in collaboration with Dr G. Dunn) indicate that gp37-specific Fab causes FS9 cells to become contact inhibited following heterotypic collisions with fibroblasts. Instead of showing contact promotion, the Fab-treated FS9 cells retreat from the fibroblasts following collision.
(2) Cloning thegp37gene. We have used the mAb DD9 to purify gp37 (Fig. Id) .
The first 28 N-terminal amino acids have been sequenced. A data bank search detected no known proteins with a similar sequence. We are using oligonucleotides to screen bacteriophage A gtio cDNA libraries for the relevant gene. We have synthesized a 16-amino acid peptide corresponding to the N-terminal sequence of gp37 and used it to obtain polyclonal antibodies specific for gp37 (Ingrid Siefert, Diplomarbeit, Universities of Zurich and Freiburg i. Breisgau, 1987) . These antibodies and the mAbs are being used to screen a Agtn expression library for the gene. Once the gene is obtained, transformation experiments can be used to discover whether introducing the protein into non-invasive cells is sufficient to make them invasive in vitro and in vivo. Mechanisms by which the gene is regulated can also be studied. Moreover, knowledge of the amino acid sequence will provide information about the structure/function of gp37 and its relationship to other proteins.
(3) Ubiquity of gp37. gp37 is not restricted to FS9 cells and we have found a variety of cell lines, including human tumours (Fig. lc) , that carry the antigen.
There is a positive correlation between the presence of gp37 and invasion in the confronted explant assay. This invasion was consistently inhibited by gp37-specific Fabs.
(4) Localization of gp37 in normal tissues. Immunohistochemical methods have to date failed to detect the antigen in normal mouse tissues. A role for gp37 in embryo development, when specific cellular invasion is occurring, could be envisaged. Hence, we are screening mouse embryo tissue for the antigen. Since so little is known about the mechanisms by which cells regulate movement and how cell contact influences these mechanisms, we can only speculate on the reasons why gp37 facilitates cellular invasion. According to the concept of non reciprocity (Heaysman, 1970) , FS9 cells are strong emittors and so gp37 may be part of the emission mechanism. Its presence may prevent the information deriving from cell contact from being translated into cell movement. Fab binding to gp37 may ch an ge its c o n fo rm atio n an d 'u n co u p le it' from the regu latory sy ste m , i.e . block its in h ib ito ry effect. T h e tran sien t asso ciatio n of sp ecific recep to rs on ad jac en t cells m ay in d u c e cell w ith d raw al an d , if g p 3 7 itself can act as a re ce p to r p o sitiv ely co u p le d to th e reg u lato ry sy stem , its levels on the cell su rfac e m ay be so h igh th at in su fficie n t m o lecu les are b o u n d to activate the con tact in h ibitio n m ach in ery . In su c h a case, F a b b in d in g m ig h t sim u late h etero typ ic cell con tact, alth ou gh th is im p lie s F a b w ould p e rm a n en tly activate the w ithdraw al m ech an ism . H ow ever, no ab e rran t F S 9 cell b e h a v io u r is o b se rv e d . I f con tact in volves local bioch em ical ch an g es in the cell (e .g . 
EMBRYONIC DEVELOPMENT
Vertebrate embryonic development involves dramatic changes in the relative position of single cells, cell masses and extracellular domains. Both types of invasion discussed above are presumably involved in these changes and may employ mechanisms similar or identical to those bestowing metastatic potential on tumour cells. Cell surface proteins (Edelman, 1985) and the extracellular matrix (see below) have been implicated in embryonic cell migration and pattern formation.
Virtually all migrating mesenchymal cells synthesize sulphated macromolecules during active translocation. On the basis of studies of cardiac mesenchymal cell migration, Fundenburg & Markwald (1986) have presented a 'substratum condition ing' model for cell movement. Mesenchymal cells migrate on and through a scaffold of collagen fibrils in situ, translocation probably being the accumulative result of synchronous series of attachment-detachment events. The model proposes that chondroitin sulphate proteoglycans secreted by the cells mask the substratum and prevent static cycles of reattachment at the same site. This would provide for directed and sustained cell movement, migration of the population ultimately being inhibited.
In avian embryos, sclerotome cells radiate from the somites towards the notochord to occupy the perichordal space. Neural crest cells (NC), however, do not enter the perichordal space (Newgreen et al. 1986) . In vitro experiments showed that the notochord prevented NC, but not sclerotome cells, from occupying adjacent collagen gel and fibronectin-rich extracellular matrix substrates. The inhibition of NC was a local phenomenon, occurring close to the notochord and not requiring direct contact. (It was not absolute, as NC prevented from moving elsewhere could approach the notochord.) The notochord avoidance by NC was abolished by including testicular hyaluronidase and chondroitinase ABC in the culture medium, suggesting differen tial responses to the extracellular material (e.g. chondroitin sulphate proteoglycan) may be responsible for the distribution of NC and sclerotome cells. Other aspects of sclerotome and NC mesenchyme cell morphogenesis cannot, however, be explained by such cell-extracellular matrix interactions.
CONCLUSIONS
Comparative studies on metastatic and non-metastatic tumour cells have pin pointed a variety of properties that may be required at specific points in the metastatic cascade. These changes are complex; however, the underlying mechan isms may be associated with the activation (or repression) of only a few genes. Hopes that D N A transfection experiments will identify such regulatory genes must be tempered by the discovery that the transformation process itself can alter the metastatic properties of neoplastic cells (Kerbel et al. 1987) . Identification of genes regulating the invasion-like behaviour of embryonic cells may provide the longawaited breakthrough. This will require the development of suitable in vitro systems, even though extrapolation to the in vivo situation can be tenuous. The cellular collisions studied by Abercrombie and his colleagues are, for technical reasons, only easily observable in sparse culture. Nevertheless, the confronted explant assay has convincingly shown a correlation between the lack of heterotypic contact inhibition in vitro and invasive behaviour in vivo. The reasons why the 37K tumour cell protein influences cellular invasion in culture are quite unknown, as is the relevance of this protein to metastasis. However, it has provided us with a 'tool' for dissecting the molecular mechanisms responsible for such invasion. A ltv o g t, P ., F o g e l, M ., C h e in g so n g -P o p o v , R ., D e n n is, J ., R o b in so n , P. & S c h irrm a c h e r, D a n o , K ., A n d re a s e n , P. A ., G r o n d a h l-H a n s e n , J ., K ris te n s e n , B., N ie ls e n , L . S. & S k riv e r, L . (1985) . Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44, 146-239. D e n n is, J ., W a lle r , C., T im p l, R. & S c h irrm a c h e r, V. (1982) . Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature, Lond. 300,
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